386 related articles for article (PubMed ID: 22231446)
1. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
4. Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells.
Attema JL; Bert AG; Lim YY; Kolesnikoff N; Lawrence DM; Pillman KA; Smith E; Drew PA; Khew-Goodall Y; Shannon F; Goodall GJ
PLoS One; 2013; 8(9):e75517. PubMed ID: 24086551
[TBL] [Abstract][Full Text] [Related]
5. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between microRNA expression and DNA methylation drives the hormone-dependent phenotype of breast cancer.
Aure MR; Fleischer T; Bjørklund S; Ankill J; Castro-Mondragon JA; ; Børresen-Dale AL; Tost J; Sahlberg KK; Mathelier A; Tekpli X; Kristensen VN
Genome Med; 2021 Apr; 13(1):72. PubMed ID: 33926515
[TBL] [Abstract][Full Text] [Related]
7. miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer.
Augoff K; McCue B; Plow EF; Sossey-Alaoui K
Mol Cancer; 2012 Jan; 11():5. PubMed ID: 22289355
[TBL] [Abstract][Full Text] [Related]
8. Methylated DNA binding domain protein 2 (MBD2) coordinately silences gene expression through activation of the microRNA hsa-mir-496 promoter in breast cancer cell line.
Alvarado S; Wyglinski J; Suderman M; Andrews SA; Szyf M
PLoS One; 2013; 8(10):e74009. PubMed ID: 24204564
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
11. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer.
Vrba L; Muñoz-Rodríguez JL; Stampfer MR; Futscher BW
PLoS One; 2013; 8(1):e54398. PubMed ID: 23342147
[TBL] [Abstract][Full Text] [Related]
12. MYC and DNMT3A-mediated DNA methylation represses microRNA-200b in triple negative breast cancer.
Pang Y; Liu J; Li X; Xiao G; Wang H; Yang G; Li Y; Tang SC; Qin S; Du N; Zhang H; Liu D; Sun X; Ren H
J Cell Mol Med; 2018 Dec; 22(12):6262-6274. PubMed ID: 30324719
[TBL] [Abstract][Full Text] [Related]
13. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients.
Kolacinska A; Morawiec J; Pawlowska Z; Szemraj J; Szymanska B; Malachowska B; Morawiec Z; Morawiec-Sztandera A; Pakula L; Kubiak R; Zawlik I
DNA Cell Biol; 2014 Sep; 33(9):624-9. PubMed ID: 24865188
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
15. Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women.
Oltra SS; Peña-Chilet M; Vidal-Tomas V; Flower K; Martinez MT; Alonso E; Burgues O; Lluch A; Flanagan JM; Ribas G
Sci Rep; 2018 Sep; 8(1):14373. PubMed ID: 30258192
[TBL] [Abstract][Full Text] [Related]
16. Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.
Köhler CU; Bryk O; Meier S; Lang K; Rozynek P; Brüning T; Käfferlein HU
Biochem Biophys Res Commun; 2013 Aug; 438(1):48-53. PubMed ID: 23867826
[TBL] [Abstract][Full Text] [Related]
17.
Anwar SL; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Buurman R; Skawran B; Lehmann U
World J Gastroenterol; 2017 Mar; 23(9):1568-1575. PubMed ID: 28321157
[TBL] [Abstract][Full Text] [Related]
18. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
Braicu C; Raduly L; Morar-Bolba G; Cojocneanu R; Jurj A; Pop LA; Pileczki V; Ciocan C; Moldovan A; Irimie A; Eniu A; Achimas-Cadariu P; Paradiso A; Berindan-Neagoe I
J Exp Clin Cancer Res; 2018 Oct; 37(1):257. PubMed ID: 30342533
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
20. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]